|
|
|
Insider
Information: |
Sigal Elliot |
Relationship: |
Director |
City: |
Princeton |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
148,221 |
|
Indirect Shares
|
78,638 |
|
|
Direct
Value |
$5,965,895 |
|
|
Indirect Value
|
$5,479,085 |
|
|
Total
Shares |
226,859 |
|
|
Total
Value |
$11,444,981 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bristol-Myers Squibb Co |
BMY |
EVP, CSO & President R... |
2013-06-03 |
148,221 |
2013-06-03 |
47,079 |
Premium* |
|
Mead Johnson Nutrition Co |
MJN |
Director |
2017-06-15 |
0 |
2017-06-15 |
0 |
Premium* |
|
Spark Therapeutics, Inc. |
ONCE |
Director |
2019-12-17 |
0 |
2015-02-04 |
31,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
133 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2007-09-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,871) |
172,282 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
officerTitle |
|
2007-03-02 |
4 |
D |
$26.42 |
$25,865 |
D/D |
(979) |
174,941 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President PRI |
|
2007-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,038) |
175,920 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President PRI |
|
2007-03-06 |
4 |
D |
$27.01 |
$28,415 |
D/D |
(1,052) |
176,153 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President PRI |
|
2007-03-06 |
4/A |
D |
$27.01 |
$28,415 |
D/D |
(1,052) |
176,153 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2009-03-06 |
4 |
D |
$18.35 |
$51,288 |
D/D |
(2,795) |
176,708 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President PRI |
|
2007-03-06 |
4 |
A |
$27.01 |
$61,151 |
D/D |
2,264 |
177,205 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President PRI |
|
2007-03-06 |
4/A |
A |
$27.01 |
$61,151 |
D/D |
2,264 |
177,205 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2009-04-30 |
4 |
B |
$19.18 |
$287,700 |
D/D |
15,000 |
178,376 |
2.74 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President PRI |
|
2007-02-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,150) |
178,958 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2009-03-02 |
4 |
D |
$17.74 |
$17,385 |
D/D |
(980) |
179,503 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
CSO & President PRI |
|
2006-11-01 |
4 |
D |
$24.76 |
$75,221 |
D/D |
(3,038) |
180,108 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2009-03-01 |
4 |
D |
$18.41 |
$38,587 |
D/D |
(2,096) |
180,483 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2009-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
28,700 |
182,579 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
CSO & President PRI |
|
2006-09-08 |
4 |
D |
$22.96 |
$69,752 |
D/D |
(3,038) |
183,146 |
|
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2013-03-07 |
4 |
D |
$37.53 |
$2,816,214 |
D/D |
(75,039) |
185,021 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
CSO & President PRI |
|
2006-03-07 |
4 |
D |
$22.73 |
$42,323 |
D/D |
(1,862) |
186,184 |
|
- |
|
BMY |
Bristol-Myers Squibb Co |
CSO & President PRI |
|
2006-03-07 |
4 |
A |
$22.73 |
$638,872 |
D/D |
28,107 |
188,046 |
|
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2010-03-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(33,393) |
189,651 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2010-03-07 |
4 |
D |
$24.60 |
$87,428 |
D/D |
(3,554) |
189,785 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2010-03-06 |
4 |
D |
$24.60 |
$78,400 |
D/D |
(3,187) |
193,339 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2010-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,875 |
196,526 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(50,096) |
200,400 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-05-18 |
4 |
D |
$28.70 |
$4,313,747 |
D/D |
(150,299) |
205,902 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-03-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,796) |
207,107 |
0 |
- |
|
133 Records found
|
|
Page 4 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|